{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-102146","form_type":"8-K","ticker":"CDXS","cik":"0001200375","company_name":"CODEXIS, INC.","filed_at":"2026-03-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.651971+00:00","generated_at":"2026-05-15T14:42:12.948551+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Codexis Q4 revenue jumps 81% to $38.9M, net income of $9.6M; FY2025 revenue up 19%","bullets":["Q4 2025 revenue of $38.9M (up 81% YoY); net income $9.6M vs net loss of $10.4M in Q4 2024.","FY2025 total revenue $70.4M (+19% YoY); product gross margin improved to 64% from 56%.","FY2025 net loss narrowed to $44.0M ($0.50 per share) from $65.3M ($0.89 per share) in FY2024.","Cash and investments $78.2M; management expects cash runway through 2027.","Introduced FY2026 revenue guidance of $72M-$76M; highlights include $37.8M Merck tech transfer deal and multiple partnerships."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-102146","json":"https://secwatch.observer/filing/0001193125-26-102146.json","markdown":"https://secwatch.observer/filing/0001193125-26-102146.md","text":"https://secwatch.observer/filing/0001193125-26-102146.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1200375/000119312526102146/0001193125-26-102146-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1200375/000119312526102146/d106216d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T14:42:12.948551+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}